At a press conference, Minister of Health, Labor and Welfare Goto said that the new Corona drug would be delivered to 490,000 people developed by Merck and 125,000 people developed by Pfizer by the end of this month.
Among them, Minister of Health, Labor and Welfare Goto has agreed to supply the new corona drug "Lagebrio" developed by American pharmaceutical giant Merck within the fiscal year for 800,000 people, of which 350,000 people have so far. However, it is expected that an additional 140,000 people will be delivered within the month, and 490,000 people will be delivered by the end of this month.
In addition, 40,000 people have been delivered to Pfizer, a major American pharmaceutical company, and 85,000 additional people have been delivered by the end of this month, totaling 120,000 by the end of this month. He said that 5,000 people would be delivered.
In addition, the infusion drug Sotrovimab from British pharmaceutical giant GlaxoSmithKline has been delivered for 90,000 people by the beginning of this month, and 80,000 people scheduled to be delivered early next month will be delivered earlier this week. It means that it will be delivered at.
Minister Goto said, "We recognize that if we think it is necessary in the medical field, the administration will not be hindered by not being able to obtain it or not receiving it. The government will also secure and supply therapeutic drugs. We will continue to do our utmost to do our best. "